Immunobiology

Papers
(The H4-Index of Immunobiology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab117
Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies62
The role of dectin-1 in health and disease52
Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling39
SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 1935
Regulatory role of Apelin-13-mediated PI3K/AKT signaling pathway in the glucose and lipid metabolism of mouse with gestational diabetes mellitus25
What do we know about the antibody responses to SARS-CoV-2?25
Advances in immunotherapy for the treatment of spinal cord injury25
Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) b24
Nanoparticle-induced immune response: Health risk versus treatment opportunity?22
Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus21
Roles of protein ubiquitination in inflammatory bowel disease19
MiR-183-5p overexpression in bone mesenchymal stem cell-derived exosomes protects against myocardial ischemia/reperfusion injury by targeting FOXO119
CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender19
A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites18
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know17
Effects of TNF-α on autophagy of rheumatoid arthritis fibroblast-like synoviocytes and regulation of the NF-κB signaling pathway17
MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-1917
BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-1917
0.053938150405884